EVE shot up 20% today on this news...
EVE Investments strikes deal with OpenDNA to sweeten Meluka Honey impact in China
Health and nutrition investment company
EVE Investments (ASX: EVE) has struck a timely deal with
OpenDNA (ASX: OPN) in a bid to improve its marketing and sales support for its range of honey products into the Chinese market.
The deal was said to be a “win-win for both companies”, according to OpenDNA’s CEO Bryan Carr.
EVE Investments said that its wholly-owned subsidiary Meluka Honey had signed a binding agreement with the artificial intelligence and e-commerce marketing company for an initial 12-month period with an opportunity to extend the deal by a further 12 months if required.
The deal announced today hopes to integrate OpenDNA’s RooLife platform – with Meluka’s activities to continuously assess and refine the products offered to customers while gathering intelligence about its customers’ preferences and buying habits.
OpenDNA says this will, in turn, provide merchants such as Meluka Honey, with valuable insights into their end customers in China.
EVE Investments said that the two primary factors driving demand in the Chinese market are the strong belief in the natural medicinal properties of honey coupled with its trust in the quality and safety of Australian made products.
More...